Drugs / MMC
last change Sep 2014 re-read 2 minutes ago

MMC

Developed for
glaucoma

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00661583 Comparator Apr 2008 → Sep 2014 glaucoma University of Colorado, Denver Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as MMC ClinicalTrials.gov intervention name — accepted as the source's own label NCT00661583
Route Topical topically applied MMC (0.4 mg/mL for 2 min)” PMID 20570237 Jun 2010